Katherina Morawski

827 total citations
16 papers, 633 citations indexed

About

Katherina Morawski is a scholar working on Transplantation, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Katherina Morawski has authored 16 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Transplantation, 8 papers in Epidemiology and 7 papers in Psychiatry and Mental health. Recurrent topics in Katherina Morawski's work include Renal Transplantation Outcomes and Treatments (15 papers), Cytomegalovirus and herpesvirus research (8 papers) and Neurological Complications and Syndromes (7 papers). Katherina Morawski is often cited by papers focused on Renal Transplantation Outcomes and Treatments (15 papers), Cytomegalovirus and herpesvirus research (8 papers) and Neurological Complications and Syndromes (7 papers). Katherina Morawski collaborates with scholars based in United States and United Kingdom. Katherina Morawski's co-authors include Miguel S. West, Scott A. Gruber, Jose M. El‐Amm, Abdolreza Haririan, James Garnick, Dale H. Sillix, Pranatharthi Chandrasekar, George Alangaden, Rama Thyagarajan and Atul Kumar Singh and has published in prestigious journals such as Transplantation, American Journal of Transplantation and The American Journal of Surgery.

In The Last Decade

Katherina Morawski

16 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherina Morawski United States 11 354 299 147 107 98 16 633
Dale H. Sillix United States 12 306 0.9× 271 0.9× 143 1.0× 82 0.8× 111 1.1× 15 635
Miguel S. West United States 15 445 1.3× 324 1.1× 245 1.7× 129 1.2× 143 1.5× 23 807
Jose M. El‐Amm United States 11 334 0.9× 306 1.0× 138 0.9× 124 1.2× 106 1.1× 13 601
James Garnick United States 10 300 0.8× 278 0.9× 138 0.9× 94 0.9× 88 0.9× 11 559
Jean-Pierre Venetz Switzerland 14 326 0.9× 227 0.8× 185 1.3× 110 1.0× 46 0.5× 36 704
Richard Rohrer United States 11 229 0.6× 291 1.0× 155 1.1× 80 0.7× 112 1.1× 20 611
Vinita Sehgal United States 14 609 1.7× 235 0.8× 363 2.5× 79 0.7× 78 0.8× 20 897
Francis H. Wright United States 16 460 1.3× 240 0.8× 352 2.4× 104 1.0× 202 2.1× 39 906
Fernando Macário Portugal 15 244 0.7× 120 0.4× 171 1.2× 104 1.0× 161 1.6× 66 593
Isabelle Cardeau‐Desangles France 16 357 1.0× 234 0.8× 243 1.7× 323 3.0× 104 1.1× 24 1.0k

Countries citing papers authored by Katherina Morawski

Since Specialization
Citations

This map shows the geographic impact of Katherina Morawski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherina Morawski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherina Morawski more than expected).

Fields of papers citing papers by Katherina Morawski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherina Morawski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherina Morawski. The network helps show where Katherina Morawski may publish in the future.

Co-authorship network of co-authors of Katherina Morawski

This figure shows the co-authorship network connecting the top 25 collaborators of Katherina Morawski. A scholar is included among the top collaborators of Katherina Morawski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherina Morawski. Katherina Morawski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gruber, Scott A., et al.. (2010). Different patterns of cancer incidence among African American and Caucasian renal allograft recipients. Surgery. 148(4). 661–666. 1 indexed citations
2.
Doshi, Mona D., et al.. (2010). Does donor race still make a difference in deceased-donor African-American renal allograft recipients?. The American Journal of Surgery. 199(3). 305–309. 5 indexed citations
3.
El‐Amm, Jose M., Mona D. Doshi, Atul Kumar Singh, et al.. (2009). Outcome predictors in African‐American deceased‐donor renal allograft recipients. Clinical Transplantation. 23(4). 454–461. 7 indexed citations
4.
Gruber, Scott A., Jose M. El‐Amm, Atul Kumar Singh, et al.. (2009). Equivalent outcomes with primary and retransplantation in African-American deceased-donor renal allograft recipients. Surgery. 146(4). 646–653. 13 indexed citations
5.
El‐Amm, Jose M., Mona Doshi, Atul Kumar Singh, et al.. (2008). Intermediate-term outcomes of hepatitis C-positive compared with hepatitis C-negative deceased-donor renal allograft recipients. The American Journal of Surgery. 195(3). 298–303. 9 indexed citations
6.
Gruber, Scott A., Mona Doshi, Atul Kumar Singh, et al.. (2008). Preliminary Experience With Renal Transplantation in HIV+ Recipients: Low Acute Rejection and Infection Rates. Transplantation. 86(2). 269–274. 48 indexed citations
7.
El-Amm, J.M., Mona Doshi, Atul Kumar Singh, et al.. (2007). Preliminary Experience With Cinacalcet Use in Persistent Secondary Hyperparathyroidism After Kidney Transplantation. Transplantation. 83(5). 546–549. 47 indexed citations
8.
El‐Amm, Jose M., Mona D. Doshi, Atul Kumar Singh, et al.. (2007). Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy. Surgery. 142(4). 538–545. 15 indexed citations
9.
Haririan, Abdolreza, Katherina Morawski, Miguel S. West, et al.. (2007). Sirolimus exposure during the early post‐transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients. Clinical Transplantation. 21(4). 466–471. 23 indexed citations
10.
Haririan, Abdolreza, Omar R. Fagoaga, Katherina Morawski, et al.. (2006). Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African‐American renal transplant cohort. Clinical Transplantation. 20(2). 226–233. 30 indexed citations
11.
Alangaden, George, Rama Thyagarajan, Scott A. Gruber, et al.. (2006). Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clinical Transplantation. 20(4). 401–409. 318 indexed citations
12.
Haririan, Abdolreza, Dale H. Sillix, Katherina Morawski, et al.. (2006). Short-Term Experience with Early Steroid Withdrawal in African-American Renal Transplant Recipients. American Journal of Transplantation. 6(10). 2396–2402. 32 indexed citations
13.
Gruber, Scott A., James Garnick, Katherina Morawski, et al.. (2005). Cytomegalovirus prophylaxis with valganciclovir in African–American renal allograft recipients based on donor/recipient serostatus. Clinical Transplantation. 19(2). 273–278. 23 indexed citations
14.
Haririan, Abdolreza, Katherina Morawski, Dale H. Sillix, et al.. (2005). Induction Therapy with Basiliximab versus Thymoglobulin in African-American Kidney Transplant Recipients. Transplantation. 79(6). 716–721. 50 indexed citations
15.
Gruber, Scott A., Miguel S. West, Dale H. Sillix, et al.. (2005). Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients. Surgery. 138(4). 772–779. 11 indexed citations
16.
Haririan, Abdolreza, Katherina Morawski, James Garnick, et al.. (2004). EXPERIENCE WITH THYMOGLOBULIN (ATG) AND BASILIXIMAB (BSX) INDUCTION IN AFRICAN AMERICAN (AA) RENAL ALLOGRAFT RECIPIENTS. Transplantation. 78. 265–265. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026